The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Moderna’s investigational mRNA vaccine for respiratory syncytial virus (RSV) in adult patients....
Predictive analytics, the use of data, algorithms and visualizations to forecast outcomes, is being increasingly used in drug development and clinical trial design....
A team of researchers at the University of Wisconsin–Madison has successfully combined genomics with machine learning in the quest to develop accessible tests that allow earlier detection of cancer....
The COVID-19 pandemic radically changed our perspectives on how to conduct research and clinical care, and it set the stage for data-driven biomedical research and clinical practice....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
Clinical researchers and study teams around the globe have widely adopted technology solutions that will forever change how clinical trials are designed and conducted moving forward....
Wisconsin could be at the center of a regional medical physics hub that would be a catalyst for scientific breakthroughs and innovative companies that transform and extend human life....
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
The University of Wisconsin–Madison ranks eighth in national research rankings for public and private universities and increased research expenditures across all fields....
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
